Determination of 5-S-cysteinyldopa in plasma and urine using a fully automated solid-phase extraction--high-performance liquid chromatographic method for an improvement of specificity and sensitivity of this prognostic marker of malignant melanoma.
Hartleb, J
Determination of 5-S-cysteinyldopa in plasma and urine using a fully automated solid-phase extraction--high-performance liquid chromatographic method for an improvement of specificity and sensitivity of this prognostic marker of malignant melanoma. [electronic resource] - Journal of chromatography. B, Biomedical sciences and applications Apr 1999 - 31-42 p. digital
Publication Type: Journal Article
1387-2273
10.1016/s0378-4347(99)00098-5 doi
Automation
Biomarkers, Tumor--blood
Calibration
Case-Control Studies
Chromatography, High Pressure Liquid--methods
Cysteinyldopa--blood
Humans
Melanoma--blood
Prognosis
Reference Standards
Reproducibility of Results
Sensitivity and Specificity
Skin Neoplasms--blood
Determination of 5-S-cysteinyldopa in plasma and urine using a fully automated solid-phase extraction--high-performance liquid chromatographic method for an improvement of specificity and sensitivity of this prognostic marker of malignant melanoma. [electronic resource] - Journal of chromatography. B, Biomedical sciences and applications Apr 1999 - 31-42 p. digital
Publication Type: Journal Article
1387-2273
10.1016/s0378-4347(99)00098-5 doi
Automation
Biomarkers, Tumor--blood
Calibration
Case-Control Studies
Chromatography, High Pressure Liquid--methods
Cysteinyldopa--blood
Humans
Melanoma--blood
Prognosis
Reference Standards
Reproducibility of Results
Sensitivity and Specificity
Skin Neoplasms--blood